Hypaconine
Hypaconine exhibits strong cardiac activity.
Inquire / Order:
manager@chemfaces.com
Technical Inquiries:
service@chemfaces.com
Tel:
+86-27-84237783
Fax:
+86-27-84254680
Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to
24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
Sci Rep.2021, 11(1):10931.
Nutrients.2022, 14(16):3393.
NanoBioScience2024, v13:3:115.
Rep.Grant.Res.,Asahi Glass Foun.2023, No.119.
Phytomedicine.2019, 59:152785
Phytomedicine.2018, 47:48-57
Patanjali Research Foundation2024, ssrn.4807357
Sci Rep.2017, 7(1):3249
Molecules.2023, 28(5):2376.
Eur J Pharmacol.2024, 981:176883.
Related and Featured Products
Nat Prod Commun. 2012 Jun;7(6):713-20.
Structure-cardiac activity relationship of C19-diterpenoid alkaloids.[Pubmed:
22816290]
Thirty three C19-diterpenoid alkaloids, twenty-two prepared from known C19-diterpenoid alkaloids and eleven isolated from Aconitum and Delphinium spp. were evaluated for their cardiac activity in the isolated bullfrog heart assay.
METHODS AND RESULTS:
Among them, eleven compounds exhibited cardiac activity, with average rate of amplitude increase in the range of 16-118%. Compound 7, mesaconine (17), Hypaconine (25), and beiwutinine (26) exhibited strong cardiac activities relative to the reference drug.
CONCLUSIONS:
The structure-activity relationship data acquired indicated that an alpha-hydroxyl group at C-15, a hydroxyl group at C-8, an alpha-methoxyl or hydroxyl group at C-1, and a secondary amine or N-methyl group in ring A are important structure features necessary for the cardiac activities of the aconitine-type C19-diterpenoid alkaloids without any ester groups. In addition, an alpha-hydroxyl group at C-3 is also helpful for the cardiac activity of these alkaloids.
